Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.

Identifieur interne : 004E41 ( Main/Exploration ); précédent : 004E40; suivant : 004E42

How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.

Auteurs : Chandrakant Lahariya [Inde] ; Shailendra S. Tomar

Source :

RBID : pubmed:21406730

Descripteurs français

English descriptors

Abstract

Lymphatic filariasis (LF) is endemic in 81 countries in the world, and a number of these countries have targeted for LF elimination. This review of literature and analysis was conducted to identify additional and sustainable strategies to accelerate LF elimination from endemic countries. This review noted that adverse events due to mass drug administration (MDA) of diethyl carbamazine (DEC) tablets, poor knowledge and information about LF amongst health workers & community members, and limited focus on information, education & communication (IEC) activities and interpersonal communication are the major barriers in LF elimination. The new approaches to increase compliance with DEC tablets (including exploring the possibility for DEC fortification of salt), targeted education programmes for physicians and health workers, and IEC material and inter personal communication to improve the knowledge of community are immediately required. There is a renewed and pressing need to conduct operational research, evolve sustainable and institutional mechanisms for education of physicians and health workers, ensure quality of trainings on MDA, strengthen IEC delivery mechanisms, implement internal and external monitoring of MDA activities, sufficient funding in timely manner, and to improve political and programmatic leadership. It is also time that lessons from other elimination programmes are utilized to accelerate targeted LF elimination from the endemic countries.

PubMed: 21406730


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.</title>
<author>
<name sortKey="Lahariya, Chandrakant" sort="Lahariya, Chandrakant" uniqKey="Lahariya C" first="Chandrakant" last="Lahariya">Chandrakant Lahariya</name>
<affiliation wicri:level="1">
<nlm:affiliation>Write Health Society for Community Health Actions, Gwalior, India. c.lahariya@gmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Write Health Society for Community Health Actions, Gwalior</wicri:regionArea>
<wicri:noRegion>Gwalior</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tomar, Shailendra S" sort="Tomar, Shailendra S" uniqKey="Tomar S" first="Shailendra S" last="Tomar">Shailendra S. Tomar</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21406730</idno>
<idno type="pmid">21406730</idno>
<idno type="wicri:Area/PubMed/Corpus">002710</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002710</idno>
<idno type="wicri:Area/PubMed/Curation">002710</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002710</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002710</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002710</idno>
<idno type="wicri:Area/Ncbi/Merge">004200</idno>
<idno type="wicri:Area/Ncbi/Curation">004200</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004200</idno>
<idno type="wicri:doubleKey">0972-9062:2011:Lahariya C:how:endemic:countries</idno>
<idno type="wicri:Area/Main/Merge">004E77</idno>
<idno type="wicri:Area/Main/Curation">004E41</idno>
<idno type="wicri:Area/Main/Exploration">004E41</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.</title>
<author>
<name sortKey="Lahariya, Chandrakant" sort="Lahariya, Chandrakant" uniqKey="Lahariya C" first="Chandrakant" last="Lahariya">Chandrakant Lahariya</name>
<affiliation wicri:level="1">
<nlm:affiliation>Write Health Society for Community Health Actions, Gwalior, India. c.lahariya@gmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Write Health Society for Community Health Actions, Gwalior</wicri:regionArea>
<wicri:noRegion>Gwalior</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tomar, Shailendra S" sort="Tomar, Shailendra S" uniqKey="Tomar S" first="Shailendra S" last="Tomar">Shailendra S. Tomar</name>
</author>
</analytic>
<series>
<title level="j">Journal of vector borne diseases</title>
<idno type="ISSN">0972-9062</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Communicable Disease Control (methods)</term>
<term>Diethylcarbamazine (administration & dosage)</term>
<term>Diethylcarbamazine (adverse effects)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Elephantiasis, Filarial (psychology)</term>
<term>Endemic Diseases (prevention & control)</term>
<term>Health Education</term>
<term>Health Personnel (education)</term>
<term>Health Personnel (psychology)</term>
<term>Humans</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Contrôle des maladies contagieuses ()</term>
<term>Diéthylcarbamazine (administration et posologie)</term>
<term>Diéthylcarbamazine (effets indésirables)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (psychologie)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Maladies endémiques ()</term>
<term>Personnel de santé (enseignement et éducation)</term>
<term>Personnel de santé (psychologie)</term>
<term>Éducation pour la santé</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="education" xml:lang="en">
<term>Health Personnel</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="enseignement et éducation" xml:lang="fr">
<term>Personnel de santé</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Elephantiasis, Filarial</term>
<term>Endemic Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr">
<term>Filariose lymphatique</term>
<term>Personnel de santé</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Elephantiasis, Filarial</term>
<term>Health Personnel</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Health Education</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Contrôle des maladies contagieuses</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Maladies endémiques</term>
<term>Éducation pour la santé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lymphatic filariasis (LF) is endemic in 81 countries in the world, and a number of these countries have targeted for LF elimination. This review of literature and analysis was conducted to identify additional and sustainable strategies to accelerate LF elimination from endemic countries. This review noted that adverse events due to mass drug administration (MDA) of diethyl carbamazine (DEC) tablets, poor knowledge and information about LF amongst health workers & community members, and limited focus on information, education & communication (IEC) activities and interpersonal communication are the major barriers in LF elimination. The new approaches to increase compliance with DEC tablets (including exploring the possibility for DEC fortification of salt), targeted education programmes for physicians and health workers, and IEC material and inter personal communication to improve the knowledge of community are immediately required. There is a renewed and pressing need to conduct operational research, evolve sustainable and institutional mechanisms for education of physicians and health workers, ensure quality of trainings on MDA, strengthen IEC delivery mechanisms, implement internal and external monitoring of MDA activities, sufficient funding in timely manner, and to improve political and programmatic leadership. It is also time that lessons from other elimination programmes are utilized to accelerate targeted LF elimination from the endemic countries.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Tomar, Shailendra S" sort="Tomar, Shailendra S" uniqKey="Tomar S" first="Shailendra S" last="Tomar">Shailendra S. Tomar</name>
</noCountry>
<country name="Inde">
<noRegion>
<name sortKey="Lahariya, Chandrakant" sort="Lahariya, Chandrakant" uniqKey="Lahariya C" first="Chandrakant" last="Lahariya">Chandrakant Lahariya</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E41 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E41 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21406730
   |texte=   How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21406730" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024